Scorpius Holdings, Inc. SCPX

SCPX Company Overview

Scorpius Holdings, Inc. is a U.S.-based biotechnology and pharmaceutical services company operating in the life sciences, biologics manufacturing, and contract development and manufacturing organization (CDMO) industries. The company’s activities span biologics development, advanced pharmaceutical manufacturing services, and technology-enabled solutions supporting drug developers. Its primary revenue drivers are centered on fee-for-service manufacturing, development services, and ancillary technology platforms designed to support biopharmaceutical production.

Formerly known as Heat Biologics, Inc., the company historically focused on immuno-oncology and vaccine development before undertaking a strategic transformation. Beginning in 2022–2023, Scorpius shifted away from internal drug discovery toward building an integrated biologics services platform. This evolution was driven by acquisitions and internal restructuring aimed at addressing growing demand for flexible, domestic biologics manufacturing capacity, particularly among small and mid-sized biotechnology companies.